<unk>  is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler.
Indacaterol
Abiraterone acetate
Olodaterol
Ingenol mebutate
Semagacestat
Quingestanol acetate
Dienogest
Bisoctrizole